Mindray, a leading Chinese medical device manufacturer, has won two awards in the Product Launches category in the 2023 Medical Device Network Excellence Awards for its launches within the Defibrillators and Patient Monitoring subcategories.
The Medical Device Network Excellence Awards celebrate the greatest achievements and innovations in the medical devices industry. Powered by GlobalData’s business intelligence, the Awards recognize the people and companies that are driving change in the industry.
Mindray won the award for Defibrillators for launching the BeneHeart D60 and D30 models, which enhance emergency medical interventions with rapid response capabilities and comprehensive diagnostic tools. The company received recognition in Patient Monitoring for the launch of its mWear system, which offers continuous, patient-centric care through innovative wearable technology and seamless integration across healthcare settings.
Revolutionizing resuscitation with BeneHeart defibrillators
Mindray’s BeneHeart D60 and D30 are next-generation defibrillators engineered to enhance the efficiency and effectiveness of emergency medical interventions. With a focus on reliability and ease of use, the BeneHeart series incorporates high-definition capacitive touch screens and gesture-control technology, allowing for seamless operation even in high-pressure situations.
Key features of the BeneHeart defibrillators include:
QShock Technology: This feature significantly reduces charging and interruption times, enabling faster defibrillation, which is crucial in emergency scenarios. The ability to power on and deliver a shock in less than five seconds exemplifies the device’s efficiency.
Comprehensive CPR Evaluation System: Provides real-time feedback on the performance of resuscitation teams, thereby improving the quality of care delivered to patients. The system includes structured debriefing protocols that automatically record and upload rescue data, facilitating continuous improvement in resuscitation practices.
Advanced Diagnostic Tools: The BeneHeart D60 includes professional 12-lead ECG analysis and point-of-care ultrasound capabilities, allowing clinicians to make informed decisions quickly. These tools are essential for diagnosing chest pain conditions and identifying myocardial infarction locations, which can be critical in pre-hospital environments.
The defibrillators are also designed to withstand demanding conditions, featuring water and dust proofing, drop protection, and the ability to operate in extreme temperatures ranging from -20°C to 55°C. This robustness ensures that the devices can be relied upon in various emergency settings, further contributing to their award-winning status.
Enhancing patient monitoring with the mWear system
Mindray’s mWear system has been recognized for its ability to provide continuous, patient-centric care. This wearable monitoring solution is designed to seamlessly integrate into both hospital and home settings, offering a comprehensive view of a patient’s health status. The mWear system monitors vital signs such as respiration rate, temperature, oxygen saturation, and pulse rate, ensuring accurate and reliable data collection.
One of the standout features of the mWear system is its patented Anti-motion Algorithm, which minimizes false alarms and allows patients to move freely without compromising data accuracy. This innovation addresses a common challenge in wearable monitoring devices, enhancing both patient comfort and clinical efficiency. The system’s ability to accurately capture physical activities and sleep patterns provides healthcare providers with a holistic view of a patient’s recovery journey.
The mWear system also supports customizable measurement settings and monitoring modes, catering to diverse clinical needs. Its integration with Mindray’s IT architecture facilitates seamless data management, reducing installation and maintenance costs for healthcare providers. The use of a universal content management system (CMS) platform allows for the display, analysis, and reporting of all patient-related clinical data, ensuring that healthcare teams have access to comprehensive information for timely interventions.
Furthermore, the mWear system’s adaptability extends to home-hospital applications, where it can be used to monitor patients remotely. This capability is particularly valuable in managing chronic conditions and post-operative care, where continuous monitoring can lead to early detection of complications and improved patient outcomes. By providing early detection of vital sign changes and enabling timely interventions, the mWear system plays a pivotal role in improving patient outcomes, solidifying its position as an award-winning innovation in patient monitoring.
Mindray’s launches, thus, underscore its dedication to advancing healthcare technology and improving patient care. The BeneHeart defibrillators and mWear monitoring system exemplify Mindray’s innovative approach to addressing critical clinical needs. By combining cutting-edge technology with user-friendly designs, Mindray continues to influence the medical device industry, enhancing the quality of care for patients worldwide.
Company Profile
Mindray is a leading global provider of medical devices and solutions, committed to advancing healthcare accessibility worldwide. With a vision of “Better healthcare for all,” the company addresses the pressing challenges of the healthcare industry, such as an aging population, rising costs, and the need for service integration. Mindray’s mission is to optimize and share medical technologies to improve patient care, ensuring that high-quality healthcare is within reach for more people. The company collaborates closely with the medical community to understand and respond to patient needs, delivering reliable and easy-to-use solutions that prioritize patient care. Mindray’s core values—aligning with customers, valuing and enriching people, being precise and practical, and always forging ahead—guide its operations and foster a culture of innovation and excellence.
Founded 30 years ago, Mindray has grown into a multinational company with a robust international presence, boasting over 60 subsidiaries across more than 190 countries and regions. The company employs over 18,000 people globally, with a significant focus on research and development, as evidenced by its 12 R&D centers and over 4,800 R&D experts. Mindray invests more than 10% of its annual revenue in R&D, resulting in over 11,130 patent applications. Its innovations span a broad spectrum of the medical industry, offering integrated solutions that enhance efficiency and management for healthcare providers. Mindray’s products are trusted by top-tier hospitals worldwide, including 99% of Tier 1 hospitals in China and nine of the top ten cardiac hospitals in the U.S. Committed to sustainability, Mindray integrates corporate strategy with social responsibility, aiming to contribute significantly to human health and sustainable medical care.
Contact Details
Mindray Building,
Keji 12th Road South,
High-Tech Industrial Park,
Nanshan, Shenzhen, 518057, P. R. China
Tel: +86 755 8188 8997
Links
